CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that Mr. Jeffrey Capello, Senior Vice President and Chief Financial Officer of PerkinElmer, Inc. has been appointed to its Board of Directors.
